RADIOIMMUNOTHERAPY CASES REGISTRY: RECURRENT OR REFRACTORY NON-HODGKIN LYMPHOMA TREATED WITH 90Y-IBRITUMOMAB TIUXETAN

被引：0
|
作者：
Gomez-Codina, J. [1 ]
Giraldo, P. [2 ]
机构：
[1] Univ Hosp La Fe, Valencia, Spain
[2] Hosp U Miguel Servet, Dept Haematol, Zaragoza, Spain
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [1] Registry of radioimmunotherapy: Analysis of outcomes of recurrent or refractory Non-Hodgkin Lymphoma patients treated with 90Y Ibritumomab tiuxetan
    Giraldo, P.
    Codina, J. Gomez
    ANNALS OF ONCOLOGY, 2008, 19 : 208 - 208
  • [2] Registry of radioimmunotherapy: Analysis of outcomes of recurrent or refractory non-Hodgkin lymphoma patients treated with 90Y Ibritumomab tiuxetan
    Giraldo, Pilar
    Codina, Jose Gomez
    Feixeira, Adriana
    Hernando, Teresa
    Tisaire, Jose Luis
    BLOOD, 2007, 110 (11) : 190B - 190B
  • [3] Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma
    Marcus, R
    SEMINARS IN ONCOLOGY, 2005, 32 (01) : S36 - S43
  • [4] ANALYSIS OF OUTCOMES AND FOLLOW-UP IN NON-HODGKIN LYMPHOMA PATIENTS TREATED WITH 90Y-IBRITUMOMAB TIUXETAN FOR RECURRENT OR REFRACTORY DISEASE. DATA OBTAINED FROM RADIOIMMUNOTHERAPY REGISTRY
    Giraldo, P. G.
    Gomez Codina, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 106 - 107
  • [5] Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan
    Brockmann, H
    Biersack, HJ
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (09) : 438 - 440
  • [6] Assessment of Metabolic Response to Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
    Storto, Giovanni
    De Renzo, Amalia
    Pellegrino, Teresa
    Perna, Fabiana
    De Falco, Teresa
    Erra, Paola
    Nardelli, Anna
    Speranza, Antonio
    Klain, Michele
    Rotoli, Bruno
    Pace, Leonardo
    RADIOLOGY, 2010, 254 (01) : 245 - 252
  • [7] RIT WITH 90Y-IBRITUMOMAB TIUXETAN IMPROVES THE RESPONSE IN AGGRESSIVE NON-HODGKIN LYMPHOMA
    Montes Limon, A.
    Andrade Campos, M.
    Murillo Flores, I.
    Grasa Ulrich, J. M.
    Lievano, P.
    Baringo, T.
    Giraldo Castellanos, P.
    HAEMATOLOGICA, 2012, 97 : 667 - 668
  • [8] Radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin®)
    Bello, P.
    Almoguera, M. I.
    Pajares, M.
    Olivas, C.
    Lapena, L.
    Freire, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2010, 29 (01): : 50 - 52
  • [9] SINGLE CENTER EXPERIENCE OF 90Y-IBRITUMOMAB TIUXETAN IN THE OLDER POPULATION WITH NON-HODGKIN LYMPHOMA
    Agrawal, V.
    Castillo, J.
    Raup, K.
    Girton, T.
    Collins, S.
    Brady, J.
    Vadakara, J.
    Khan, S.
    HAEMATOLOGICA, 2016, 101 : 481 - 482
  • [10] Safety and efficacy of external beam radiation therapy for non-Hodgkin lymphoma in patients with prior 90Y-ibritumomab tiuxetan radioimmunotherapy
    Justice, Terry E.
    Martenson, James A.
    Wiseman, Gregory A.
    Witzig, Thomas E.
    CANCER, 2006, 107 (02) : 433 - 438
12345